[google-translator]

17-OHP

Disorder: Endocrine

Condition: Congenital Adrenal Hyperplasia (CAH)

Biomarker: 17-hydroxyprogesterone (17-OHP)

The 17-OHP (17-hydroxyprogesterone) assay is intended for the quantitative determination of 17-OHP concentrations in dried neonatal whole blood specimens. Measurement of 17-OHP is used as a primary screen in the diagnosis and treatment of classical congenital adrenal hyperplasia (CAH) in newborns, an inborn error of cortisol hormone production. 

For more information, visit Congenital Adrenal Hyperplasia

 

PRODUCT HIGHLIGHTS

• 30-day prepared reagent stability – Reduced reagent prep frequency
• Options of 3 hour or overnight assay protocols – Flexible timeline to fit your laboratory’s needs
• Single plate elution allows for semi-plexing with other immunoassays – Reduced microplate usage with efficient workflow
• Multi-analyte calibrators and controls in DBS format – Simplified workflow with complementary assays

For In Vitro Diagnostic Use.  This device is intended for use by trained, qualified laboratory personnel.

PRODUCT ORDERING INFORMATION

SPOTCHECK® NEONATAL 17-OHP MICROPLATE REAGENT KIT CONFIGURATIONS

PART NO.DESCRIPTIONCONTENTS
85-2000-05K/KE5 PlateDried blood spot calibrators and controls, antibody coated microplates, all reagents
85-2000-20K/KE20 PlateDried blood spot calibrators and controls, antibody coated microplates, all reagents
DOWNLOAD OUR BROCHURE